646 related articles for article (PubMed ID: 26411550)
21. Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy.
Klatte T; Seligson DB; LaRochelle J; Shuch B; Said JW; Riggs SB; Zomorodian N; Kabbinavar FF; Pantuck AJ; Belldegrun AS
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):894-900. PubMed ID: 19240241
[TBL] [Abstract][Full Text] [Related]
22. p21-activated kinase 1 predicts recurrence and survival in patients with non-metastatic clear cell renal cell carcinoma.
Zhu Y; Xu L; An H; Liu W; Wang Z; Xu J
Int J Urol; 2015 May; 22(5):447-53. PubMed ID: 25711487
[TBL] [Abstract][Full Text] [Related]
23. Increased expression of interleukin-8 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma.
An H; Zhu Y; Xie H; Liu Y; Liu W; Fu Q; Ye D; Xu J
Tumour Biol; 2016 Apr; 37(4):4523-9. PubMed ID: 26503211
[TBL] [Abstract][Full Text] [Related]
24. CXC chemokine receptor 2 is associated with postoperative recurrence and survival of patients with non-metastatic clear-cell renal cell carcinoma.
An H; Xu L; Chang Y; Zhu Y; Yang Y; Chen L; Lin Z; Xu J
Eur J Cancer; 2015 Sep; 51(14):1953-61. PubMed ID: 26188847
[TBL] [Abstract][Full Text] [Related]
25. High expression of chemokine CCL2 is associated with recurrence after surgery in clear-cell renal cell carcinoma.
Yang Y; Zhai C; Chang Y; Zhou L; Shi T; Tan C; Xu L; Xu J
Urol Oncol; 2016 May; 34(5):238.e19-26. PubMed ID: 26749463
[TBL] [Abstract][Full Text] [Related]
26. Notch1 predicts recurrence and survival of patients with clear-cell renal cell carcinoma after surgical resection.
An H; Zhu Y; Xu L; Chen L; Lin Z; Xu J
Urology; 2015 Feb; 85(2):483.e9-483.e14. PubMed ID: 25559729
[TBL] [Abstract][Full Text] [Related]
27. Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up.
Minardi D; Lucarini G; Filosa A; Milanese G; Zizzi A; Di Primio R; Montironi R; Muzzonigro G
Int J Immunopathol Pharmacol; 2008; 21(2):447-55. PubMed ID: 18547492
[TBL] [Abstract][Full Text] [Related]
28. TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma.
Glaser ZA; Love HD; Guo S; Gellert L; Chang SS; Herrell SD; Barocas DA; Penson DF; Cookson MS; Clark PE
Urol Oncol; 2017 May; 35(5):286-293. PubMed ID: 28108243
[TBL] [Abstract][Full Text] [Related]
29. Upregulation of COL6A1 is predictive of poor prognosis in clear cell renal cell carcinoma patients.
Wan F; Wang H; Shen Y; Zhang H; Shi G; Zhu Y; Dai B; Ye D
Oncotarget; 2015 Sep; 6(29):27378-87. PubMed ID: 26317545
[TBL] [Abstract][Full Text] [Related]
30. Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma.
White-Al Habeeb NM; Di Meo A; Scorilas A; Rotondo F; Masui O; Seivwright A; Gabril M; Girgis AH; Jewett MA; Yousef GM
Clin Exp Metastasis; 2015 Aug; 32(6):531-41. PubMed ID: 26037892
[TBL] [Abstract][Full Text] [Related]
31. Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification.
Kanao K; Mizuno R; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Nakashima J; Oya M
J Urol; 2009 Feb; 181(2):480-5; discussion 485. PubMed ID: 19100568
[TBL] [Abstract][Full Text] [Related]
32. Elevated expression of IFN-inducible CXCR3 ligands predicts poor prognosis in patients with non-metastatic clear-cell renal cell carcinoma.
Liu W; Liu Y; Fu Q; Zhou L; Chang Y; Xu L; Zhang W; Xu J
Oncotarget; 2016 Mar; 7(12):13976-83. PubMed ID: 26910919
[TBL] [Abstract][Full Text] [Related]
33. High expression of CXC chemokine receptor 6 associates with poor prognosis in patients with clear cell renal cell carcinoma.
Chang Y; Zhou L; Xu L; Fu Q; Yang Y; Lin Z; Xu J
Urol Oncol; 2017 Dec; 35(12):675.e17-675.e24. PubMed ID: 28918166
[TBL] [Abstract][Full Text] [Related]
34. GALNT4 predicts clinical outcome in patients with clear cell renal cell carcinoma.
Liu Y; Liu W; Xu L; Liu H; Zhang W; Zhu Y; Xu J; Gu J
J Urol; 2014 Nov; 192(5):1534-41. PubMed ID: 24769034
[TBL] [Abstract][Full Text] [Related]
35. P2X7 receptor predicts postoperative cancer-specific survival of patients with clear-cell renal cell carcinoma.
Liu Z; Liu Y; Xu L; An H; Chang Y; Yang Y; Zhang W; Xu J
Cancer Sci; 2015 Sep; 106(9):1224-31. PubMed ID: 26179886
[TBL] [Abstract][Full Text] [Related]
36. Dectin-1 predicts adverse postoperative prognosis of patients with clear cell renal cell carcinoma.
Xia Y; Liu L; Bai Q; Wang J; Xi W; Qu Y; Xiong Y; Long Q; Xu J; Guo J
Sci Rep; 2016 Sep; 6():32657. PubMed ID: 27600310
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of the co-expression of carbonic anhydrase IX and vascular endothelial growth factor in patients with clear cell renal cell carcinoma.
Phuoc NB; Ehara H; Gotoh T; Nakano M; Kamei S; Deguchi T; Hirose Y
Oncol Rep; 2008 Sep; 20(3):525-30. PubMed ID: 18695901
[TBL] [Abstract][Full Text] [Related]
38. High expression of galectin-7 associates with poor overall survival in patients with non-metastatic clear-cell renal cell carcinoma.
Wang J; Liu Y; Yang Y; Xu Z; Zhang G; Liu Z; Fu H; Wang Z; Liu H; Xu J
Oncotarget; 2016 Jul; 7(27):41986-41995. PubMed ID: 27259255
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Significance of Inflammation-associated Blood Cell Markers in Nonmetastatic Clear Cell Renal Cell Carcinoma.
Lee A; Lee HJ; Huang HH; Tay KJ; Lee LS; Sim SPA; Ho SSH; Yuen SPJ; Chen K
Clin Genitourin Cancer; 2020 Aug; 18(4):304-313. PubMed ID: 31892491
[TBL] [Abstract][Full Text] [Related]
40. High Level of Anaphylatoxin C5a Predicts Poor Clinical Outcome in Patients with Clear Cell Renal Cell Carcinoma.
Xi W; Liu L; Wang J; Xia Y; Bai Q; Long Q; Wang Y; Xu J; Guo J
Sci Rep; 2016 Jul; 6():29177. PubMed ID: 27381421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
